CRISPR-mediated inactivation of Trp53 alone led to unilateral tumor formation in 50% of cases with a mean latency of 210 days (Fig. 2c), essentially mimicking pleomorphic sarcoma formation in germline-mediated mouse models of Li-Fraumeni syndrome32,33. This evidence concerns the gene TP53 and neoplasm.